Results 181 to 190 of about 7,581 (239)

Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22. [PDF]

JAC Antimicrob Resist
Wise MG, DeRyke CA, Alekseeva I, Siddiqui F, Young K, Motyl MR, Sahm DF.   +6 more
europepmc   +1 more source

Garai et al.; A novel mechanism of ceftolozane-tazobactam resistance in Pseudomonas aeruginosa mediated by L2 β-lactamase; (Raw data files); 2026

Preeti Garai
openalex   +1 more source

Ceftolozane/Tazobactam for the Treatment of Adults With Cystic Fibrosis: Results From a French Prospective Cohort Study. [PDF]

Open Forum Infect Dis
Burgel PR, Bourge X, Mackosso C, Parquin F.   +3 more
europepmc   +1 more source

A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar? [PDF]

J Antimicrob Chemother
Gatti M, Rinaldi M, Bonazzetti C, Siniscalchi A, Tonetti T, Ambretti S, Giannella M, Viale P, Pea F.   +8 more
europepmc   +1 more source

Clinical outcomes and emergence of resistance of <i>Pseudomonas aeruginosa</i> infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam. [PDF]

Antimicrob Agents Chemother
Hareza DA, Cosgrove SE, Bonomo RA, Dzintars K, Karaba SM, Hawes AM, Tekle T, Simner PJ, Tamma PD.   +8 more
europepmc   +1 more source

Ceftolozane/tazobactam in action: Prescribing patterns, effectiveness, and healthcare utilisation across seven countries

Emre Yücel, Àlex Soriano, David L. Paterson, Florian Thalhalmmer, Stefan Kluge, Pierluigi Viale, Mike Allen, Brune Akrich, Jessica Levy, Huina Yang, Sunny Kaul   +10 more
openalex   +1 more source

Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings-A French Real-world Study. [PDF]

Open Forum Infect Dis
Timsit JF, Mootien J, Akrich B, Bourge X, Brassac I, Castan B, Mackosso C, Tavares LM, Ruiz F, Boutoille D, Ruimy R.   +10 more
europepmc   +1 more source

Mutations leading to ceftolozane/tazobactam and imipenem/cilastatin/relebactam resistance during <i>in vivo</i> exposure to ceftazidime/avibactam in <i>Pseudomonas aeruginosa</i>. [PDF]

Microbiol Spectr
Rapsinski GJ, Rokes AB, Van Tyne D, Cooper VS.   +3 more
europepmc   +1 more source

Effect of Ceftaroline, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam on Establishment of Colonization by Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice. [PDF]

Pathog Immun
Hausman BS, Memic S, Cadnum JL, Zink EG, Wilson BM, Donskey CJ.   +5 more
europepmc   +1 more source